Hunan Hansen Pharmaceutical Co., Ltd. 2025 Annual Report of Independent Director
Hunan Hansen Pharmaceutical Co., Ltd. 2025 Annual Report of Independent Director (Xia Song)
As an independent director of Hunan Hansen Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company"), I have conscientiously and diligently fulfilled my duties in accordance with the requirements of the Company Law, Securities Law, and the Articles of Association. During 2025, I actively attended relevant meetings, diligently reviewed all proposals submitted to the Board of Directors, and fully utilized my role as an independent director and member of various special committees to effectively protect the interests of the Company and its shareholders, especially small and medium shareholders. This report outlines my performance as an independent director in 2025:
I. Basic Information
I, Xia Song, born in June 1975, am a Certified Public Accountant, Asset Appraiser, and Lawyer. I have previously served as Investment Director at Kaivin Huacheng Investment Management Co., Ltd. in Changdu, Head of Internal Audit at Jiajia Food Group Co., Ltd., Independent Director at Tianzhu Culture Co., Ltd., Independent Director at Hunan Feiwor New Energy Technology Co., Ltd., and currently serve as Independent Director of Hunan Hansen Pharmaceutical Co., Ltd.
During the reporting period, I held no positions in the Company other than that of an independent director, nor did I hold any positions in the principal shareholders' companies. I have no conflict of interest with the Company or its principal shareholders, or any other relationship that could hinder my independent and objective judgment. My appointment meets the independence requirements stipulated in Article 6 of the "Administrative Measures for Independent Directors of Listed Companies," and there are no circumstances that affect my independence.